HealthTech Deep Dive

HealthTech Deep Dive

By Kazutaka YoshinagaNewsBusiness News
Download on the App Store

HealthTech Deep Dive episodes

  • Can a Wearable Really Track Your Hormones Without a Blood Draw? The Science Behind Clair Health

    The provided text details the emergence of two innovative healthcare companies, Clair Health and Xella Health, which utilize advanced technology to address long-standing gaps in women's medical diagnostics. Clair Health has developed a non-invasive wearable device that employs artificial intelligence and ten distinct sensors to estimate hormone fluctuations in real time by monitoring physiological markers like skin temperature and heart rate. Meanwhile, Xella Health offers a precision health platform that combines blood testing with multi-omics analysis to identify over 130 conditions frequently misdiagnosed in women, such as endometriosis and PCOS. Both startups secured significant seed funding in June 2026, reflecting a growing investor interest in femtech solutions that empower individuals to access their own biological data. While their approaches differ—one focusing on continuous monitoring and the other on deep-dive diagnostics—both aim to modernize the understanding of the menstrual cycle beyond traditional models. Despite their promise, the sources note that these technologies are currently positioned as wellness tools and still require rigorous independent clinical validation and FDA approval.

    22 min
  • Midjourney Enters Healthcare With a Full-Body Ultrasound Scanner: Why Is an AI Image Generation Company Trying to "See Inside the Body"?

    The AI image-generation company Midjourney has expanded into the medical field with the announcement of its Midjourney Scanner, a high-speed, low-cost full-body ultrasound system. Utilizing specialized chip-based sensor technology licensed from Butterfly Network, the device aims to provide rapid cross-sectional imaging without the risks of radiation associated with CT scans. To navigate regulatory hurdles, the company is positioning the tool for body composition and wellness tracking rather than formal medical diagnosis. This strategy includes a plan to open Midjourney Spa locations, which integrate clinical-grade hardware into a lifestyle environment for regular health monitoring. While the project sets ambitious goals for processing speed and affordability, its long-term success depends on future technical verification and large-scale clinical adoption.

    22 min
  • Adaptive Innovations: What Happens When You Build a Home Health Agency Around AI From Day One

    The provided text details the emergence of Adaptive Innovations, a Texas-based startup that secured $50 million in Series A funding to transform home healthcare through an AI-native provider model. Unlike traditional companies that add digital tools to existing workflows, this firm functions as a licensed medical entity where specialized AI agents autonomously handle administrative tasks like intake, scheduling, and billing. By drastically reducing paperwork and overhead, the company aims to reinvest its savings into higher clinician pay and superior patient outcomes, reporting a significantly lower re-hospitalization rate than the national average. The sources also compare this "AI-native operator" approach to established tech clinics like One Medical, highlighting how Adaptive prioritizes operational efficiency over physical storefronts. Finally, the text examines the challenges of replicating this model in Japan, citing complex insurance regulations and the difficulty for startups to secure clinical designations.

    21 min
  • Why Doesn’t the Oura Ring 5’s Blood Pressure Feature Display Readings?—Patterns Captured by Nighttime PPG, FDA Strategy, and Interpreting the Dexcom Partnership

    The provided source details the launch of the Oura Ring 5, a next-generation smart ring that marks the company's transition from a sleep tracker to a comprehensive metabolic health platform. A central focus is the new "Blood Pressure Signals" feature, which identifies long-term cardiovascular trends and nighttime dipping patterns rather than providing specific numerical measurements. This strategic design allows the device to function as a wellness tool rather than a regulated medical device, encouraging users to consult doctors when abnormal patterns emerge. Additionally, the source highlights a significant partnership with Dexcom to integrate glucose monitoring and specialized insights for users of GLP-1 weight-loss medications. Technological upgrades, such as a redesigned sensor with twelve signal paths, further improve data accuracy across diverse skin tones and finger shapes. Ultimately, these updates signify a shift toward integrated health management through partnerships with medical guidance and diagnostic services.

    22 min
  • Triomics Raised $22M for Oncology AI Workflows. Here's the Real Competitive Landscape — and Why 1 in 7 UK Adults Now Use AI Instead of a Doctor.

    The provided reports examine the evolving role of artificial intelligence in modern healthcare, focusing on both institutional and consumer-level applications. Triomics, a specialized oncology startup, recently secured $22 million in funding by streamlining complex cancer records and automating clinical workflows for major medical centers. In contrast, a study from the United Kingdom reveals that many citizens now use AI chatbots as a substitute for professional medical consultations, leading a significant portion to skip doctor visits entirely. This shift highlights critical concerns regarding patient safety and the potential for misdiagnosis, as evidenced by the historical collapse of the telehealth firm Babylon Health. Ultimately, while specialized AI offers efficiency for healthcare providers, the rise of consumer-facing bots presents complex challenges for traditional medical systems and public health outcomes.

    21 min
  • New BCI Research on Training the Brain’s “On/Off” Switch — Can Visualizing Brain Activity During Mental Rehearsal Improve Motor Skills?

    The provided sources detail cutting-edge developments in HealthTech, focusing on advancements in brain-computer interfaces (BCI) and AI-driven drug discovery. One report highlights a study where neurofeedback training allows individuals to visualize and control brain states, effectively "transferring" mental imagery practice into improved physical motor performance. Simultaneously, the text discusses Isomorphic Labs, an Alphabet subsidiary that secured $2.1 billion in funding to scale its IsoDDE engine. This AI platform significantly outperforms previous models in predicting how drug molecules bind to proteins, potentially unlocking treatments for previously unreachable diseases. Together, these sources illustrate a future where technology enhances human biology and computational intelligence reshapes the pharmaceutical industry.

    23 min
  • Mayo Clinic’s AI Detects Pancreatic Cancer Up to Three Years in Advance: A Breakthrough in Early Detection, or the Beginning of New Challenges?

    The provided documents highlight significant advancements in medical artificial intelligence, focusing on two breakthrough diagnostic models released in 2026. The Mayo Clinic’s REDMOD utilizes radiomics to analyze abdominal CT scans, enabling the detection of pancreatic cancer up to three years before a standard clinical diagnosis. In a parallel development, the startup Noetik introduced TARIO-2, a foundational model that predicts the expression of 19,000 genes using only common, low-cost H&E stained pathology images. Both technologies aim to improve patient outcomes by extracting subvisual biological data that remains invisible to even the most experienced human specialists. These sources emphasize a shifting paradigm where AI functions as a seamless co-pilot within existing hospital workflows rather than requiring new, expensive infrastructure. Ultimately, these tools represent a move toward precision medicine by identifying early-stage tumors and molecular characteristics with unprecedented speed and accuracy.

    13 min
  • “Koroyawa,” a fracture-prevention mat, raised 1.28 billion yen. But can a mat really soften only during a fall?

    The provided sources detail two significant breakthroughs in medical AI aimed at enhancing diagnostic capabilities without disrupting existing hospital workflows. First, the Mayo Clinic developed the REDMOD AI, which utilizes human-engineered radiomics to detect pancreatic cancer signs on standard CT scans up to three years earlier than clinical diagnosis. Second, the startup Noetik introduced TARIO-2, a foundation model that predicts roughly 19,000 gene expression patterns directly from inexpensive, routine H&E tissue stains. While the Mayo Clinic's model relies on specific mathematical filters to highlight invisible textures, Noetik's system uses self-supervised learning to uncover complex biological relationships beyond human perception. Together, these technologies suggest a future where AI co-pilots act as a double-check for specialists, significantly improving early detection and personalized treatment insights. By integrating seamlessly with standard imaging and pathology, these tools offer a scalable path toward high-precision medicine.

    23 min
  • Google Unveils the Screenless “Fitbit Air” and an AI Personal Coach. Will It Be a Strong Contender Against Whoop? The New Trend of Screens + AI

    The provided text details Google’s 2026 announcement of the Fitbit Air, a lightweight, screenless wearable designed to compete with the fitness tracker Whoop. Priced at $99, this device prioritizes passive data collection and long battery life over the interactive features found in traditional smartwatches. Alongside the hardware, Google introduced the Google Health Coach, a Gemini-powered AI that provides personalized lifestyle suggestions through the rebranded Google Health app. While Whoop targets elite athletes with high-frequency heart rate monitoring and human-led on-demand medical consultations, Google aims for a broader market by focusing on affordability and AI-driven behavioral change. This strategic shift signals Google’s intent to unify its health platform around generative AI interpretation rather than just hardware interfaces. Ultimately, the industry is moving toward a model where wearable technology and artificial intelligence work together to translate biometric data into actionable health improvements.

    21 min
  • “Koroyawa,” a mat designed to reduce the risk of fractures from falls, has raised 1.28 billion yen. But is it really possible for a mat to “become soft only when someone falls”?

    The sources highlight two innovative health and safety initiatives: the development of Koroyawa shock-absorbing flooring and a public safety partnership involving Pokémon GO. Magic Shields has secured significant funding for their specialized mats that utilize mechanical metamaterials to stay firm during walking but turn soft to prevent fractures during a fall. This technology aims to reduce the massive social and medical costs associated with elderly bone injuries in Japan's aging society. Simultaneously, the sources describe a collaboration between Niantic and the Japan AED Foundation that integrates real-world AED locations into the mobile game as "PokéStops." By utilizing gamification, the project encourages players to subconsciously memorize the positions of life-saving equipment while they explore their cities. Together, these updates represent a trend of using cutting-edge engineering and augmented reality to address critical public health challenges.

    21 min

About HealthTech Deep Dive

From the publisher's feed

Welcome to Health Tech Deep Dive, the podcast that delves into the forefront of healthcare technology and innovation, exploring transformative advancements from around the globe. Each episode uncovers how groundbreaking ideas and cutting-edge technologies are pushing the boundaries of what’s possible in the field of health tech, with a special focus on the interplay between global trends and localized innovation.